NaNotics is a preclinical-stage biopharmaceutical company is developing NaNots™, novel subtractive nanoparticles that treat disease by capturing and clearing pathogenic molecules from blood.
Investors 4
Mentions in press and media 3
| Date | Title | Description |
| 27.09.2024 | SPACE-H Accelerator to Explore Astronaut Disease Treatment in Space | What You Should Know:
– NaNotics LLC, a biopharmaceutical company developing NaNots® – novel subtractive nanoparticles that treat disease by capturing and clearing pathogenic molecules from blood – today announced that it has been selected ... |
| 31.10.2023 | NaNotics Receives Investment From LifeSpan Vision Ventures | LifeSpan Vision Ventures Invests in NaNotics
NaNotics, a Mill Valley, CA-based preclinical-stage biopharmaceutical company, received an investment from LifeSpan Vision Ventures.
The amount of the deal was not disclosed.
The company intends ... |
| 31.10.2023 | LifeSpan Vision Ventures Invests in NaNotics | NORWALK, Conn., Oct. 31, 2023 /PRNewswire/ -- LifeSpan Vision Ventures, an investment firm dedicated to longevity biotech, today announced an investment in NaNotics LLC. This preclinical-stage biopharmaceutical company is developing NaNots™... |
Reviews 0
